Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Procept Biorobotics's Business Segments
Procept Biorobotics's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
4
Largest Segment
Non-US
Total Revenue
$ 94
Regions Reported
1
Revenue Share by Reportable Segment - FY
- Non-US23.5%
- Hand Pieces and Other Consumables14%
- System Sales and Leases7.7%
- Service Revenue1.8%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 22 | 23.5% |
| Hand Pieces and Other Consumables | $ 13 | 14% |
| System Sales and Leases | $ 7 | 7.7% |
1 more segments available
Sign in to unlock the full Procept Biorobotics dataset.
Revenue Share by Region - FY
- Non-US13.4%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 11 | 13.4% |
Revenue by Product & Service Category - FY
- Hand Pieces and Other Consumables51.9%
- System Sales and Rentals28.2%
- Service Revenue6.8%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Hand Pieces and Other Consumables | $ 43 | 51.9% |
| System Sales and Rentals | $ 23 | 28.2% |
| Service Revenue | $ 6 | 6.8% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Non-US23.5%
- Hand Pieces and Other Consumables14%
- System Sales and Leases7.7%
- Service Revenue1.8%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 22 | 23.5% |
| Hand Pieces and Other Consumables | $ 13 | 14% |
| System Sales and Leases | $ 7 | 7.7% |
1 more segments available
Sign in to unlock the full Procept Biorobotics dataset.
Description of Procept Biorobotics
Procept Biorobotics Corporation is a cutting-edge medical technology company that specializes in the development and manufacturing of robotic surgical systems. The company was founded in 2013 and is headquartered in Redwood City, California.
The main focus of Procept Biorobotics is to revolutionize the field of urology through the development of innovative robotic surgical systems. The company has developed a groundbreaking platform called Aquablation, which uses robotics and real-time image guidance to perform precise and controlled waterjet ablation procedures. Aquablation is designed to treat patients with lower urinary tract symptoms caused by an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH).
BPH affects millions of men worldwide and can lead to various urinary complications, such as frequent urination, weak urine flow, and inability to completely empty the bladder. Traditional treatment methods involve medication or surgical procedures that can be invasive and have potential side effects. Procept Biorobotics aims to address these issues by offering a minimally invasive, precise, and efficient solution with Aquablation.
The Aquablation platform consists of an advanced robotic system that utilizes a high-precision waterjet to remove excess prostate tissue while preserving surrounding tissues. The system is controlled by a surgeon who uses a console to manipulate the robotic arms and perform the procedure. Real-time imaging and mapping technology provide visual guidance, ensuring the precise removal of targeted tissue.
One of the key advantages of Aquablation is its ability to offer predictable and reproducible outcomes. The robotic system provides accurate tissue removal, minimizing the risk of complications and improving patient outcomes. The technology also reduces the need for post-operative catheterization, allowing patients to recover faster and return to their normal activities sooner.
Procept Biorobotics has conducted extensive clinical trials and received regulatory approvals for Aquablation in multiple countries, including the United States. The company continues to collaborate with leading urologists and academic institutions to further advance the technology and expand its applications.
In addition to its groundbreaking technology, Procept Biorobotics is known for its commitment to patient care and surgeon satisfaction. The company offers comprehensive training and support programs to ensure that surgeons are proficient in using the Aquablation system and can provide the best possible outcomes for their patients.
Overall, Procept Biorobotics Corporation is a pioneering medical technology company that is transforming the field of urology with its innovative Aquablation platform. With a focus on precision, efficiency, and patient-centered care, the company aims to improve the lives of millions of men worldwide suffering from BPH.
The main focus of Procept Biorobotics is to revolutionize the field of urology through the development of innovative robotic surgical systems. The company has developed a groundbreaking platform called Aquablation, which uses robotics and real-time image guidance to perform precise and controlled waterjet ablation procedures. Aquablation is designed to treat patients with lower urinary tract symptoms caused by an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH).
BPH affects millions of men worldwide and can lead to various urinary complications, such as frequent urination, weak urine flow, and inability to completely empty the bladder. Traditional treatment methods involve medication or surgical procedures that can be invasive and have potential side effects. Procept Biorobotics aims to address these issues by offering a minimally invasive, precise, and efficient solution with Aquablation.
The Aquablation platform consists of an advanced robotic system that utilizes a high-precision waterjet to remove excess prostate tissue while preserving surrounding tissues. The system is controlled by a surgeon who uses a console to manipulate the robotic arms and perform the procedure. Real-time imaging and mapping technology provide visual guidance, ensuring the precise removal of targeted tissue.
One of the key advantages of Aquablation is its ability to offer predictable and reproducible outcomes. The robotic system provides accurate tissue removal, minimizing the risk of complications and improving patient outcomes. The technology also reduces the need for post-operative catheterization, allowing patients to recover faster and return to their normal activities sooner.
Procept Biorobotics has conducted extensive clinical trials and received regulatory approvals for Aquablation in multiple countries, including the United States. The company continues to collaborate with leading urologists and academic institutions to further advance the technology and expand its applications.
In addition to its groundbreaking technology, Procept Biorobotics is known for its commitment to patient care and surgeon satisfaction. The company offers comprehensive training and support programs to ensure that surgeons are proficient in using the Aquablation system and can provide the best possible outcomes for their patients.
Overall, Procept Biorobotics Corporation is a pioneering medical technology company that is transforming the field of urology with its innovative Aquablation platform. With a focus on precision, efficiency, and patient-centered care, the company aims to improve the lives of millions of men worldwide suffering from BPH.
Procept Biorobotics Corporation specializes in the development and commercialization of advanced surgical robotic systems, primarily targeting the urology sector. The company is dedicated to enhancing surgical precision and patient outcomes through innovative robotic technology. Below is an extensive overview of the various segments, products, and services associated with Procept Biorobotics Corporation:
Segments
1. Robotic Surgery:
- Procept focuses on robotic-assisted surgical procedures, particularly within urology. Their systems aim to streamline surgical workflows, increase accuracy, and reduce recovery times for patients.
2. Urology:
- This is the core focus area for Procept. The company develops technology specifically for treating urologic conditions, including benign prostatic hyperplasia (BPH) and prostate cancer. Their robotic systems help physicians perform minimally invasive surgeries more effectively.
3. Research and Development:
- Procept invests heavily in R&D to advance their robotic technologies and expand their applications. This segment is crucial for continuous innovation and meeting the evolving needs of surgeons and patients.
4. Clinical Training and Support:
- The company provides training and ongoing support for medical professionals utilizing their robotic systems, ensuring that surgeons are well-versed in the technology and can maximize its potential in the surgical setting.
Products
1. PROCEPT Biorobotics System:
- This is the flagship product, a robotic-assisted surgical system specifically designed for urologic procedures. The system allows for more precise manipulations, enhanced visualization, and improved ergonomics for surgeons.
2. Aquablation® Therapy:
- A standout procedure offered by Procept, Aquablation utilizes waterjet technology to ablate (remove) prostate tissue. The procedure is guided by real-time imaging, allowing surgeons to minimize damage to surrounding tissues, resulting in fewer side effects compared to traditional treatments.
3. Integration with Imaging Technologies:
- The robotic systems integrate with advanced imaging modalities to enhance visualization and accuracy during procedures. This integration ensures that surgeons can make informed decisions based on real-time data.
4. Accessories and Instruments:
- Procept offers a range of surgical instruments and accessories that complement their robotic systems. These tools are designed for enhanced functionality and are integral to the Aquablation procedure.
Services
1. Training Programs:
- Procept provides comprehensive training programs for medical professionals, including hands-on workshops, simulation training, and mentorship opportunities to ensure effective use of their robotic systems.
2. Clinical Support:
- The company offers clinical support services to healthcare providers, including on-site support during surgeries, troubleshooting, and assistance with system operation to enhance surgical outcomes.
3. Research Collaboration:
- Procept engages in partnerships with academic institutions and research organizations to advance the study of robotic surgical techniques and outcomes.
4. Patient Education:
- The company also focuses on educating patients about their surgical options, particularly regarding the benefits of minimally invasive techniques like Aquablation. This inclusion empowers patients in their treatment decisions.
5. Regulatory Affairs and Compliance:
- Procept navigates the regulatory landscape to ensure that their products meet necessary safety and efficacy standards. This segment plays a vital role in the development cycle of new technologies.
In summary, Procept Biorobotics Corporation is at the forefront of integrating advanced robotic technologies into urologic surgical practices, providing a comprehensive suite of products and services that enhance surgical precision, improve patient outcomes, and streamline workflows for medical professionals. Their commitment to innovation and clinical excellence positions them as a key player in the field of robotic surgery.
Segments
1. Robotic Surgery:
- Procept focuses on robotic-assisted surgical procedures, particularly within urology. Their systems aim to streamline surgical workflows, increase accuracy, and reduce recovery times for patients.
2. Urology:
- This is the core focus area for Procept. The company develops technology specifically for treating urologic conditions, including benign prostatic hyperplasia (BPH) and prostate cancer. Their robotic systems help physicians perform minimally invasive surgeries more effectively.
3. Research and Development:
- Procept invests heavily in R&D to advance their robotic technologies and expand their applications. This segment is crucial for continuous innovation and meeting the evolving needs of surgeons and patients.
4. Clinical Training and Support:
- The company provides training and ongoing support for medical professionals utilizing their robotic systems, ensuring that surgeons are well-versed in the technology and can maximize its potential in the surgical setting.
Products
1. PROCEPT Biorobotics System:
- This is the flagship product, a robotic-assisted surgical system specifically designed for urologic procedures. The system allows for more precise manipulations, enhanced visualization, and improved ergonomics for surgeons.
2. Aquablation® Therapy:
- A standout procedure offered by Procept, Aquablation utilizes waterjet technology to ablate (remove) prostate tissue. The procedure is guided by real-time imaging, allowing surgeons to minimize damage to surrounding tissues, resulting in fewer side effects compared to traditional treatments.
3. Integration with Imaging Technologies:
- The robotic systems integrate with advanced imaging modalities to enhance visualization and accuracy during procedures. This integration ensures that surgeons can make informed decisions based on real-time data.
4. Accessories and Instruments:
- Procept offers a range of surgical instruments and accessories that complement their robotic systems. These tools are designed for enhanced functionality and are integral to the Aquablation procedure.
Services
1. Training Programs:
- Procept provides comprehensive training programs for medical professionals, including hands-on workshops, simulation training, and mentorship opportunities to ensure effective use of their robotic systems.
2. Clinical Support:
- The company offers clinical support services to healthcare providers, including on-site support during surgeries, troubleshooting, and assistance with system operation to enhance surgical outcomes.
3. Research Collaboration:
- Procept engages in partnerships with academic institutions and research organizations to advance the study of robotic surgical techniques and outcomes.
4. Patient Education:
- The company also focuses on educating patients about their surgical options, particularly regarding the benefits of minimally invasive techniques like Aquablation. This inclusion empowers patients in their treatment decisions.
5. Regulatory Affairs and Compliance:
- Procept navigates the regulatory landscape to ensure that their products meet necessary safety and efficacy standards. This segment plays a vital role in the development cycle of new technologies.
In summary, Procept Biorobotics Corporation is at the forefront of integrating advanced robotic technologies into urologic surgical practices, providing a comprehensive suite of products and services that enhance surgical precision, improve patient outcomes, and streamline workflows for medical professionals. Their commitment to innovation and clinical excellence positions them as a key player in the field of robotic surgery.